Bioaster-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bioaster - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011916
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioaster is a technology research institute that conducts research on infectious diseases and microbiology. The institute offers services in the therapeutic areas of respiratory diseases, diarrhea, AIDS and tuberculosis. Its technologies include biological sample collections, genomics and transcriptomics, immunomonitoring, proteins and expression system engineering, preclinical models and imaging, data management and analysis, and metabolomics and proteomics. Bioaster also offers a collaborative platform such as biospecimens, in the field of infectious diseases and microbiology. The institute works in partnership with major industrial companies, small and medium-sized enterprises (SMEs), public and private research organizations, and local authorities. Bioaster is headquartered in Lyon, France.

Bioaster – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bioaster, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioaster, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioaster, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioaster, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bioaster, Medical Devices Deals, 2011 to YTD 2017 9
Bioaster, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bioaster, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioaster, Cancer Research Center of Lyon and Janssen-Cilag Enter into Agreement 11
Bioaster Partners with Fujifilm 12
Bioaster Enters Into Co-Development Agreement With Da Volterra 13
Bioaster – Key Competitors 14
Bioaster – Key Employees 15
Bioaster – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Bioaster, Pharmaceuticals & Healthcare, Key Facts 2
Bioaster, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioaster, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioaster, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioaster, Deals By Therapy Area, 2011 to YTD 2017 8
Bioaster, Medical Devices Deals, 2011 to YTD 2017 9
Bioaster, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bioaster, Cancer Research Center of Lyon and Janssen-Cilag Enter into Agreement 11
Bioaster Partners with Fujifilm 12
Bioaster Enters Into Co-Development Agreement With Da Volterra 13
Bioaster, Key Competitors 14
Bioaster, Key Employees 15
Bioaster, Other Locations 16

★海外企業調査レポート[Bioaster-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Japan Display Inc:企業の戦略・SWOT・財務情報
    Japan Display Inc - Strategy, SWOT and Corporate Finance Report Summary Japan Display Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Ultrapar Participacoes SA (UGPA3):企業の財務・戦略的SWOT分析
    Ultrapar Participacoes SA (UGPA3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Contango Oil & Gas Co (MCF):企業の財務・戦略的SWOT分析
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …
  • Global Clean Energy Holdings Inc (GCEH):企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc (GCEH) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tabcorp Holdings Limited (TAH):企業の財務・戦略的SWOT分析
    Tabcorp Holdings Limited (TAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ACB Securities Co Ltd:企業の戦略的SWOT分析
    ACB Securities Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Alecta Pensionsforsakring Omsesidigt:企業の戦略的SWOT分析
    Alecta Pensionsforsakring Omsesidigt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Caplin Point Laboratories Ltd (CAPLIPOINT):企業の財務・戦略的SWOT分析
    Summary Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures creams, ointments, and other external application products. The company’s products in regulated market include opthalmic products, liquid injections and lyophilised injections. It also offers softgel c …
  • Covis Pharma Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Covis Pharma Sarl (Covis Pharma), a subsidiary of Concordia International Corp is a specialty pharmaceutical company that develops and markets drugs for the treatment of life-threatening conditions and chronic illnesses. The company develops products for central nervous system and rheumatic …
  • B3 S.A.
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆